Download PDF
Thorac Cardiovasc Surg 2019; 67(05): 420-424
DOI: 10.1055/s-0038-1642029
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Quality of Life: Functional Assessment of Chronic Illness Therapy after Thoracic Sympathectomy for Palmar Hyperhidrosis

Lukasz Dobosz
1   Department of General, Endocrine and Transplant Surgery, Gdanski Uniwersytet Medyczny, Gdansk, Poland
,
Tomasz Stefaniak
1   Department of General, Endocrine and Transplant Surgery, Gdanski Uniwersytet Medyczny, Gdansk, Poland
› Author Affiliations
Further Information

Publication History

30 November 2017

22 February 2018

Publication Date:
19 April 2018 (online)

    Permissions and Reprints All articles of this category

Abstract

Background Primary hyperhidrosis is a condition that significantly decreases the quality of life (QOL). Thoracic sympathectomy is safe and efficient method of treatment in palmar hyperhidrosis.

Objective The aim of the study was to evaluate the change in QOL in patients with palmar hyperhidrosis who underwent thoracic sympathectomy.

Methods The study includes 149 patients (37 men and 112 women) who were treated with bilateral thoracoscopic sympathectomy for primary palmar hyperhidrosis. Subjective and objective evaluation of hyperhidrosis were performed prior to the surgery, 3 and 12 months after the treatment. Control group consists of 305 healthy volunteers (118 men and 187 women). The QOL was measured using Functional Assessment of Chronic Illness Therapy (FACIT) scale.

Results The average level of palmar hyperhidrosis in the study group prior to surgery was 224.69 ± 179.20 mg/min/m2. General QOL (FACIT total) before the surgery was significantly lower in the study group when compared with the control group (66.57 ± 16.33 vs. 91.29 ± 11.13; p < 0.05). Three months after surgery level of hyperhidrosis decreased significantly and remained at similar level 12 months after the procedure (13.55 ± 15.41 mg/min/m2 p < 0.05 and 14.41 ± 18.19 mg/min/m2 p < 0.05, respectively). After thoracoscopic sympathectomy, the QOL increased and did not differ when compared with the control group 3 and 12 months after the surgery (90.28 ± 11.13 vs. 91.29 ± 11.13; p = 0.55 and 89.59 ± 11.34 vs. 91.29 ± 11.13; p = 0.84, respectively). The highest increase was observed in functional well-being domain (32.25%); however, it was also noticeable in other domains.

Conclusion Thoracic sympathectomy is an efficient method of treatment in palmar hyperhidrosis which significantly increases patients' QOL especially in a functional domain.

Keywords

palmar hyperhidrosis - quality of life - sympathectomy - gravimetry
 

  • References

  • 1 Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 2016; 308 (10) 743-749
    CrossrefPubMedGoogle Scholar
  • 2 Moraites E, Vaughn OA, Hill S. Incidence and prevalence of hyperhidrosis. Dermatol Clin 2014; 32 (04) 457-465
    PubMedGoogle Scholar
  • 3 de Campos JR, da Fonseca HV, Wolosker N. Quality of life changes following surgery for hyperhidrosis. Thorac Surg Clin 2016; 26 (04) 435-443
    CrossrefPubMedGoogle Scholar
  • 4 Vazquez LD, Staples NL, Sears SF, Klodell CT. Psychosocial functioning of patients after endoscopic thoracic sympathectomy. Eur J Cardiothorac Surg 2011; 39 (06) 1018-1021
    CrossrefPubMedGoogle Scholar
  • 5 Kurta AO, Glaser DA. Emerging nonsurgical treatments for hyperhidrosis. Thorac Surg Clin 2016; 26 (04) 395-402
    CrossrefPubMedGoogle Scholar
  • 6 Cerfolio RJ, De Campos JR, Bryant AS. , et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg 2011; 91 (05) 1642-1648
    CrossrefPubMedGoogle Scholar
  • 7 Stefaniak TJ, Dobosz Ł, Kaczor M, Ćwigoń M. Diagnosis and treatment of primary hyperhidrosis. Pol Przegl Chir 2013; 85 (09) 527-543
    PubMedGoogle Scholar
  • 8 Stefaniak TJ, Ćwigoń M. Long-term results of thoracic sympathectomy for primary hyperhidrosis. Pol Przegl Chir 2013; 85 (05) 247-252
    PubMedGoogle Scholar
  • 9 Stefaniak TJ, Proczko M. Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals. Clin Auton Res 2013; 23 (04) 197-200
    CrossrefPubMedGoogle Scholar
  • 10 Stefaniak T, Tomaszewski KA, Proczko-Markuszewska M, Idestal A, Royton A, Abi-Khalil C. Is subjective hyperhidrosis assessment sufficient enough? Prevalence of hyperhidrosis among young Polish adults. J Dermatol 2013; 40 (10) 819-823
    PubMedGoogle Scholar
  • 11 Schick CH, Grallath T, Schick KS, Hashmonai M. Radiofrequency thermotherapy for treating axillary hyperhidrosis. Dermatol Surg 2016; 42 (05) 624-630
    CrossrefPubMedGoogle Scholar
  • 12 Davarian S, Kalantari KK, Rezasoltani A, Rahimi A. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis. Australas J Dermatol 2008; 49 (02) 75-79
    CrossrefPubMedGoogle Scholar
  • 13 Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003; 1: 79
    CrossrefPubMedGoogle Scholar
  • 14 Ambrogi V, Campione E, Mineo D, Paternò EJ, Pompeo E, Mineo TC. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis. Ann Thorac Surg 2009; 88 (01) 238-245
    CrossrefPubMedGoogle Scholar
  • 15 Koskinen L-OD, Blomstedt P, Sjöberg RL. Predicting improvement after surgery for palmar hyperhidrosis. Acta Neurol Scand 2012; 126 (05) 324-328
    CrossrefPubMedGoogle Scholar
  • 16 Hamm H. Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin 2014; 32 (04) 467-476
    CrossrefPubMedGoogle Scholar
  • 17 Muthusamy A, Gajendran R, Ponnan S, Thangavel D, Rangan V. A study on the impact of hyperhidrosis on the quality of life among college students. J Clin Diagn Res 2016; 10 (06) CC08-CC10
    PubMedGoogle Scholar
  • 18 Kobiela J, Kaska Ł, Pindel M. , et al. Dynamics of quality of life improvement after floppy Nissen fundoplication for gastroesophageal reflux disease. Wideochir Inne Tech Malo Inwazyjne 2015; 10 (03) 389-397
    PubMedGoogle Scholar